investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

Uwe Rix

4 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Uwe Rix

Moffitt Cancer Center

Tampa, United States

University of South Florida

Tampa, United States

Thomas Metz

Oncotest GmbH

Freiburg, Germany

Related projects

Levi J Beverly

Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma

Trachea, bronchus and lung

Pathology

Fred R Hirsch

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis

Trachea, bronchus and lung

Pathology

Philip N. Tsichlis

Differential regulation of RNA processing by Akt isoforms

Trachea, bronchus and lung

Pathology

Alexander D Sorkin

Pathogenesis of Cancer: Role of EGF Receptor Endocytosis

Trachea, bronchus and lung

Pathology

Joseph R Testa

RIP1/3 Kinases as New Targets in Malignant Mesothelioma

Trachea, bronchus and lung

Pathology

Alan P Fields

Protein Kinase C Signaling Mechanisms in Cancer

Trachea, bronchus and lung

Pathology

Jeffrey Schlom

Strategies for Cancer Vaccine Development: Preclinical Studies

Trachea, bronchus and lung

Pathology

Bakhos A Tannous

Detection of NSCLC-derived Mutant RNA in Platelets

Trachea, bronchus and lung

Pathology

Martin Mcmahon

Studying the Initiation, Progression and Therapy of Lung Cancer in Mouse Models

Trachea, bronchus and lung

Pathology